IGM Biosciences (STU:1K0) Accumulated Depreciation : €0.00 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is IGM Biosciences Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

IGM Biosciences's quarterly accumulated depreciation increased from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€-18.89 Mil) but then stayed the same from Dec. 2023 (€-18.89 Mil) to Mar. 2024 (€0.00 Mil).

IGM Biosciences's annual accumulated depreciation increased from Dec. 2021 (€-5.80 Mil) to Dec. 2022 (€-11.64 Mil) and increased from Dec. 2022 (€-11.64 Mil) to Dec. 2023 (€-18.89 Mil).

IGM Biosciences Accumulated Depreciation Historical Data

The historical data trend for IGM Biosciences's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IGM Biosciences Accumulated Depreciation Chart

IGM Biosciences Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-1.14

-1.88

-5.80

-11.64

-18.89

IGM Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-18.89	-

IGM Biosciences Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

IGM Biosciences Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of IGM Biosciences's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

IGM Biosciences (STU:1K0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IGM Biosciences Inc (STU:1K0) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

IGMS:USA

Address

325 East Middlefield Road, Mountain View, CA, USA, 94043

Website

https://www.igmbio.com

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.

IGM Biosciences (STU:1K0) Headlines

No Headlines